Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP

Andrews C., Prestige E., Parker EPK., Walker V., Palmer T., Schaffer A., Green ACA., Curtis H., Walker A., Smith R., Wood C., Bates C., Mehrkar A., MacKenna B., Bacon SCJ., Goldacre B., Hernán M., Sterne JAC., Hulme W., the OpenSAFELY collaborative None.

DOI

10.1101/2024.03.15.24304277

Type

Preprint

Publication Date

2024

Keywords

the OpenSAFELY collaborative

Permalink Original publication